Search - tctmd.com

Displaying 361 - 380 of 671

Sort: Relevancy | Date

Presentation

Ticagrelor vs Clopidogrel in Patients with NSTE-ACS With or Without Revascularization

Presenter: D. Lindholm

April 25, 2014

Presentation

Heparin Monotherapy or Bivalirudin During PCI in NSTE-ACS or Stable Ischemic Heart Disease

Presenter: Sripal Bangalore

April 22, 2014

Presentation

Preprocedural Statin Use in PCI Patients

Presenter: M. Kenaan

April 21, 2014

Presentation

The Efficacy of Ticagrelor Is Maintained in Women with ACS Participating in the PLATO trial

Presenter: Steen Husted

April 16, 2014

Presentation Fellows 2014

Navigating the New Oral Anticoagulants and How to Deal with Triple Therapy

Presenter: George Dangas

April 12, 2014

Presentation Fellows 2014

Antithrombin Pharmacology for the Interventionalist

Presenter: Sunil Rao

April 12, 2014

Presentation

Impact of Early vs Late Clopidogrel Discontinuation on Stent Thrombosis Following PCI with First- and Second-Generation DES

Presenter: J.P. Loh

April 11, 2014

Presentation

Intracoronary Thrombolysis in STEMI Patients with Massive Intraluminal Thrombus, Failed Aspiration

Presenter: Daniella Boscarelli

April 10, 2014

Presentation

Onset of Antiplatelet Action with High (100 mg) vs Standard (60 mg) Loading Dose of Prasugrel in STEMI Patients Undergoing Primary PCI

Presenter: Dimitrios Alexopoulos

April 09, 2014

Presentation

Incidence and Impact of Stent Thrombosis after PCI: Comparison of Cangrelor and Clopidogrel

Presenter: Philippe Généreux

April 02, 2014

Presentation ACC 2014

Incidence and Impact of Stent Thrombosis During Percutaneous Coronary Intervention: Comparison of Cangrelor and Clopidogrel from the CHAMPION PHOENIX Trial

Presenter: Philippe Généreux

March 30, 2014

Presentation PCI Outcomes 2014

Atrial Fibrillation and PCI: Antiplatelet Therapy Recommendations

Presenter: Christopher Granger

March 28, 2014

Presentation PCI Outcomes 2014

Antiplatelet Therapy Before, During, and After PCI: Which One and How Long?

Presenter: Dominick J. Angiolillo

March 28, 2014

Presentation

Risk of Stroke in Patients with High On-Clopidogrel Platelet Reactivity to Adenosine Diphosphate after PCI

Presenter: Nevio Taglieri

March 25, 2014

Presentation

Meta-analysis of Time-Related Benefits of Statin Therapy in Patients with ACS Undergoing PCI

Presenter: Eliano Pio Navarese

March 10, 2014

Presentation

INFUSE-AMI: Outcomes in Patients with STEMI Treated with Clopidogrel vs Prasugrel

Presenter: Sorin J. Brener

February 26, 2014

Presentation

Impact of Major Bleeding on Long-term Mortality in Anemic Patients Undergoing PCI Using Bivalirudin

Presenter: Ziad A. Ali

February 25, 2014

Presentation

Cost-Effectiveness of Apixaban vs Current Standard of Care for Stroke Prevention in A-fib Patients

Presenter: Paul Dorian

February 20, 2014

Presentation

Lack of Association Between DAPT Use and Stent Thrombosis Between 1 and 12 Months Following Resolute ZES Implantation

Presenter: 115704|Sigmund Silber

February 17, 2014

Presentation

Early Post-discharge Bleeding and Antiplatelet Discontinuation in AMI Patients Treated with PCI

Presenter: 222318|Tracy Wang

February 03, 2014

Advertisement

Ticagrelor vs Clopidogrel in Patients with NSTE-ACS With or Without Revascularization

Heparin Monotherapy or Bivalirudin During PCI in NSTE-ACS or Stable Ischemic Heart Disease

Preprocedural Statin Use in PCI Patients

The Efficacy of Ticagrelor Is Maintained in Women with ACS Participating in the PLATO trial

Navigating the New Oral Anticoagulants and How to Deal with Triple Therapy

Antithrombin Pharmacology for the Interventionalist

Impact of Early vs Late Clopidogrel Discontinuation on Stent Thrombosis Following PCI with First- and Second-Generation DES

Intracoronary Thrombolysis in STEMI Patients with Massive Intraluminal Thrombus, Failed Aspiration

Onset of Antiplatelet Action with High (100 mg) vs Standard (60 mg) Loading Dose of Prasugrel in STEMI Patients Undergoing Primary PCI

Incidence and Impact of Stent Thrombosis after PCI: Comparison of Cangrelor and Clopidogrel

Incidence and Impact of Stent Thrombosis During Percutaneous Coronary Intervention: Comparison of Cangrelor and Clopidogrel from the CHAMPION PHOENIX Trial

Atrial Fibrillation and PCI: Antiplatelet Therapy Recommendations

Antiplatelet Therapy Before, During, and After PCI: Which One and How Long?

Risk of Stroke in Patients with High On-Clopidogrel Platelet Reactivity to Adenosine Diphosphate after PCI

Meta-analysis of Time-Related Benefits of Statin Therapy in Patients with ACS Undergoing PCI

INFUSE-AMI: Outcomes in Patients with STEMI Treated with Clopidogrel vs Prasugrel

Impact of Major Bleeding on Long-term Mortality in Anemic Patients Undergoing PCI Using Bivalirudin

Cost-Effectiveness of Apixaban vs Current Standard of Care for Stroke Prevention in A-fib Patients

Lack of Association Between DAPT Use and Stent Thrombosis Between 1 and 12 Months Following Resolute ZES Implantation

Early Post-discharge Bleeding and Antiplatelet Discontinuation in AMI Patients Treated with PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content